ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

RENB Renovaro Inc

1.905
0.265 (16.16%)
After Hours
Last Updated: 21:00:10
Delayed by 15 minutes
Share Name Share Symbol Market Type
Renovaro Inc NASDAQ:RENB NASDAQ Common Stock
  Price Change % Change Share Price Shares Traded Last Trade
  0.265 16.16% 1.905 1,307,358 21:00:10
Bid Price Offer Price High Price Low Price Open Price
1.86 1.92 2.00 1.44 1.5405
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations -80.65M -0.5081 -1.42 260.3M
Last Trade Time Trade Type Trade Size Trade Price Currency
21:00:03 16,047 1.905 USD

Renovaro (RENB) Latest News

Real-Time news about Renovaro Inc (NASDAQ): 0 recent articles

Renovaro Frequently Asked Questions (FAQ)

What is the current Renovaro share price?
The current share price of Renovaro is 1.905.
How many Renovaro shares are in issue?
Renovaro has 158,717,342 shares in issue.
What is the market cap of Renovaro?
The market capitalisation of Renovaro is USD 260.30 M.
What is the 1 year trading range for Renovaro share price?
Renovaro has traded in the range of US$ 0.395 to US$ 5.25 during the past year.
What is the PE ratio of Renovaro?
The price to earnings ratio of Renovaro is -1.42.
What is the reporting currency for Renovaro?
Renovaro reports financial results in USD.
What is the latest annual profit for Renovaro?
The latest annual profit of Renovaro is USD -80.65M.
What is the registered address of Renovaro?
The registered address for Renovaro is 108 W. 13TH STREET SUITE 100, NEW CASTLE, WILMINGTON, DELAWARE, 19801.
What is the Renovaro website address?
The website address for Renovaro is renovarobio.com.
Which industry sector does Renovaro operate in?
Renovaro operates in the PHARMACEUTICAL PREPARATIONS sector.